{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:55Z","timestamp":1753890955546,"version":"3.41.2"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI052056","R01 AI108421","P01 AI094420","F30 AI147881"],"award-info":[{"award-number":["R01 AI052056","R01 AI108421","P01 AI094420","F30 AI147881"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01960","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T05:22:19Z","timestamp":1597209739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rhesus Cytomegalovirus-Specific CD8+ Cytotoxic T Lymphocytes Do Not Become Functionally Exhausted in Chronic SIVmac239 Infection"],"prefix":"10.3389","volume":"11","author":[{"given":"Brandon C.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Pedre\u00f1o-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonah B.","family":"Sacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva G.","family":"Rakasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/328345a0","article-title":"HIV-specific cytotoxic T lymphocytes in seropositive individuals.","volume":"328","author":"Walker","year":"1988","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1128\/jvi.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection.","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J Exp Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/354453a0","article-title":"Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.","volume":"354","author":"Phillips","year":"1991","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nm0297-212","article-title":"Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.","volume":"3","author":"Goulder","year":"","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/35030124","article-title":"Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.","volume":"407","author":"Allen","year":"2000","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm0502-493","article-title":"Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.","volume":"8","author":"O\u2019Connor","year":"2002","journal-title":"Nat Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nri1417","article-title":"HIV and SIV CTL escape: implications for vaccine design.","volume":"4","author":"Goulder","year":"2004","journal-title":"Nat Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.","volume":"443","author":"Day","year":"2006","journal-title":"Nature."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.","volume":"203","author":"Petrovas","year":"2006","journal-title":"J Exp Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1182\/blood-2012-04-422550","article-title":"Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection.","volume":"120","author":"Trautmann","year":"2012","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1182\/blood-2007-01-069112","article-title":"SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.","volume":"110","author":"Petrovas","year":"2007","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.4049\/jimmunol.173.12.7481","article-title":"Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident ebv infection.","volume":"173","author":"Khan","year":"2004","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01776","article-title":"Cytomegalovirus-specific T cells restricted by HLA-Cw\u22170702 increase markedly with age and dominate the CD8+ T-cell repertoire in older people.","volume":"8","author":"Hosie","year":"2017","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.4049\/jimmunol.168.11.5455","article-title":"Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8 + T cell response.","volume":"168","author":"Wills","year":"2002","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1099\/vir.0.036004-0","article-title":"Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4 + and CD8 + T-cells in humans.","volume":"92","author":"Derhovanessian","year":"2011","journal-title":"J Gen Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/427828","article-title":"Dynamics of cytomegalovirus (CMV)\u2013specific T cells in HIV\u22121\u2013infected individuals progressing to AIDS with CMV end\u2212organ disease.","volume":"191","author":"Bronke","year":"2005","journal-title":"J Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1128\/jvi.77.10.5749-5758.2003","article-title":"Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian aids.","volume":"77","author":"Kaur","year":"2003","journal-title":"J Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/2326-6066.cir-15-0037","article-title":"Committing cytomegalovirus-specific CD8 T cells to eliminate tumor cells by bifunctional major histocompatibility class I antibody fusion molecules.","volume":"3","author":"Schmittnaegel","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1535-7163.MCT-16-0207","article-title":"New class of bifunctional major histocompatibility class I antibody fusion molecules to redirect CD8 T cells.","volume":"15","author":"Schmittnaegel","year":"2016","journal-title":"Mol Cancer Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.00491-18","article-title":"Antiviral activity of HIV gp120-targeting bispecific T cell engager antibody constructs.","volume":"92","author":"Brozy","year":"2018","journal-title":"J Virol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005233","article-title":"Targeting HIV reservoir in infected CD4 T cells by dual-affinity re-targeting molecules (DARTs) that bind HIV envelope and recruit cytotoxic T cells.","volume":"11","author":"Sloan","year":"2015","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5194\/pb-6-1-2019","article-title":"Seroprevalence of viral infections in captive rhesus and cynomolgus macaques.","volume":"6","author":"Kaul","year":"2019","journal-title":"Primate Biol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24197","article-title":"Immunophenotyping of rhesus CMV-specific CD8 T cell populations.","author":"Pomplun","year":"","journal-title":"Cytom Part A."},{"key":"B26","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.4049\/jimmunol.160.12.6062","article-title":"Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A\u221701) that binds an immunodominant CTL epitope from simian immunodeficiency virus.","volume":"160","author":"Allen","year":"1998","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1128\/JVI.75.2.738","article-title":"CD8+ lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A\u221701: implications for vaccine design and testing.","volume":"75","author":"Allen","year":"2001","journal-title":"J Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11623","DOI":"10.1128\/JVI.76.22.11623-11636.2002","article-title":"Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A\u221702: a paradigm for virus evolution and persistence?","volume":"76","author":"Vogel","year":"2002","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.4049\/jimmunol.173.8.5064","article-title":"Identification of seventeen new simian immunodeficiency virus-derived CD8 + T cell epitopes restricted by the high frequency molecule, Mamu-A\u221702, and potential escape from CTL recognition.","volume":"173","author":"Loffredo","year":"2004","journal-title":"J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.1128\/jvi.00601-14","article-title":"vaccination with gag, vif, and nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.","volume":"88","author":"Martins","year":"2014","journal-title":"J Virol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006529","article-title":"Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.","volume":"13","author":"Martins","year":"2017","journal-title":"PLoS Pathog."},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00690-18","article-title":"Mamu-B\u221717+ rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication.","volume":"92","author":"Martins","year":"2018","journal-title":"J Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.01626-18","article-title":"The frequency of vaccine-induced T-cell responses does not predict the rate of acquisition after repeated intrarectal SIVmac239 challenges in mamu-B\u221708 + rhesus macaques.","volume":"93","author":"Martins","year":"2019","journal-title":"J Virol."},{"journal-title":"The Use of Non-Human Primates in Research.","year":"","author":"Weatherall","key":"B34"},{"journal-title":"Guide for the Care and Use of Laboratory Animals.","year":"2011","key":"B35"},{"key":"B36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0684.2005.00128.x","article-title":"Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.","volume":"34","author":"Cline","year":"2005","journal-title":"J Med Primatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1128\/JVI.00895-07","article-title":"Mamu-B\u221708-positive macaques control simian immunodeficiency virus replication.","volume":"81","author":"Loffredo","year":"2007","journal-title":"J Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1128\/JVI.80.10.5074","article-title":"The high-frequency major histocompatibility complex class I Allele Mamu-B \u2217 17 is associated with control of simian immunodeficiency virus SIVmac239 replication.","volume":"80","author":"Yant","year":"2006","journal-title":"Society."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1172\/JCI27564","article-title":"IL-15 induces CD4+ effector memory T cell production and tissue emigration in nonhuman primates.","volume":"116","author":"Picker","year":"2006","journal-title":"J Clin Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance.","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a007252","article-title":"Vaccine design for CD8 T lymphocyte responses.","volume":"1","author":"Koup","year":"2011","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.00806.x","article-title":"Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.","volume":"115","author":"Steiner","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.4049\/jimmunol.0803771","article-title":"PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.","volume":"182","author":"Kaufmann","year":"2009","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade.","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PLoS Pathog."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.","volume":"107","author":"Curran","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1073\/pnas.1016791108","article-title":"Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance.","volume":"108","author":"Pedicord","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60738-4","article-title":"CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer.","volume":"10","author":"Friese","year":"2020","journal-title":"Sci Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-11-0407","article-title":"CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.","volume":"17","author":"Huang","year":"2011","journal-title":"Clin Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1182\/blood-2006-04-010637","article-title":"CTLA-4 blockade decreases TGF-\u03b2, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.","volume":"108","author":"Hryniewicz","year":"2006","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.4049\/jimmunol.180.8.5439","article-title":"Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection.","volume":"180","author":"Cecchinato","year":"2008","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008015","article-title":"Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques.","volume":"15","author":"Gonzalez-Nieto","year":"2019","journal-title":"PLoS Pathog."},{"key":"B53","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41591-020-0782-y","article-title":"CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.","volume":"26","author":"Harper","year":"2020","journal-title":"Nat Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T16:50:07Z","timestamp":1696524607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2020.01960"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01960","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"article-number":"1960"}}